The prescribing information for two respiratory syncytial virus (RSV) vaccines will now include a warning for the increased ...

If a threshold of 10% risk of COPD was used to make spirometry referrals, the addition of the polygenic risk score correctly ...

The stock has spent the past few years in the shadow of a COVID-19 boost, but it's time investors see the light.

It's the start of a new year, and that makes now the perfect time to load up on stocks that could boost your portfolio in ...

In an interview, the CEO discussed trying to gain support from investors hyper-focused on M&A, and competing with Pfizer and ...

In 2024, companies in the broader market that paid dividends returned around 35% of their net income and 45% of their free ...

We rate BioNTech SE a hold due to volatile performance, weak growth, and premium valuation amidst COVID-19 vaccine reliance.

The pharma expects a modest financial headwind this year from changes to Medicare prescription drug benefits under the Inflation Reduction Act.

The new data comes from the phase 3 ALLEVIATE-1 trial, which compared cebranopadol to placebo for the management of ...

A Belgian court dismissed a lawsuit against EU chief Ursula von der Leyen centered on text messages she exchanged with Pfizer ...

At J.P. Morgan, most biopharma executives expressed a neutral stance on the incoming administration, but just days later, ...

The office of the West Virginia Attorney General recently notified the Wayne County Commission that the county is expected to receive $30,000 through a settlement between the state and some ...